Detalles de la búsqueda
1.
Lung Cancer Survivorship: Physical, Social, Emotional, and Medical Needs of NSCLC Survivors.
J Natl Compr Canc Netw
; 22(1D): e237072, 2024 01 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38176099
2.
Clinical Features, Survival, and Burden of Toxicities in Survivors More Than One Year After Lung Cancer Immunotherapy.
Oncologist
; 27(11): 971-981, 2022 11 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35972337
3.
Expanding Beyond Maximum Grade: Chemotherapy Toxicity over Time by Age and Performance Status in Advanced Non-Small Cell Lung Cancer in CALGB 9730 (Alliance A151729).
Oncologist
; 26(3): e435-e444, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32951293
4.
Hospitalization and definitive radiotherapy in lung cancer: incidence, risk factors and survival impact.
BMC Cancer
; 20(1): 334, 2020 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-32306924
5.
Comparative "nocebo effects" in older patients enrolled in cancer therapeutic trials: Observations from a 446-patient cohort.
Cancer
; 123(21): 4193-4198, 2017 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28700816
6.
Neutrophil-Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Non-Small Cell Lung Cancer Treated with Combined Modality Therapy.
Oncologist
; 22(6): 737-742, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28533476
7.
Outpatient Embedded Palliative Care for Patients with Advanced Thoracic Malignancy: A Retrospective Cohort Study.
Curr Oncol
; 31(3): 1389-1399, 2024 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38534938
8.
Association of area-level mortgage denial and guideline-concordant non-small-cell lung cancer care and outcomes in the United States.
Cancer Med
; 13(3): e6921, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38205942
9.
Unmet Needs, Quality of Life, and Financial Toxicity Among Survivors of Lung Cancer.
JAMA Netw Open
; 7(4): e246872, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38630475
10.
Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses.
Nat Med
; 30(4): 1023-1034, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38504015
11.
Improved lung cancer clinical outcomes in patients with autoimmune rheumatic diseases.
RMD Open
; 9(4)2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37914179
12.
Clinician Perceptions of Barriers and Facilitators for Delivering Early Integrated Palliative Care via Telehealth.
Cancers (Basel)
; 15(22)2023 Nov 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38001600
13.
Disparities in Telemedicine Success and Their Association With Adverse Outcomes in Patients With Thoracic Cancer During the COVID-19 Pandemic.
JAMA Netw Open
; 5(7): e2220543, 2022 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35797048
14.
Real-World Outcomes and Prognostic Factors Among Patients with Advanced Non-Small Cell Lung Cancer and High PD-L1 Expression Treated with Immune Checkpoint Inhibitors as First-Line Therapy.
Cancer Manag Res
; 14: 3191-3202, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36415537
15.
Definitive Chemoradiation and Durvalumab Consolidation for Locally Advanced, Unresectable KRAS-mutated Non-Small Cell Lung Cancer.
Clin Lung Cancer
; 23(7): 620-629, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36045016
16.
Sex-specific differences in immunogenomic features of response to immune checkpoint blockade.
Front Oncol
; 12: 945798, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35992816
17.
An Oncology Urgent Care Clinic for the Management of Immune-Related Adverse Events: A Descriptive Analysis.
Curr Oncol
; 29(6): 4342-4353, 2022 06 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35735456
18.
Mutation status and postresection survival of patients with non-small cell lung cancer brain metastasis: implications of biomarker-driven therapy.
J Neurosurg
; 136(1): 56-66, 2022 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34087798
19.
Cost-effectiveness of pembrolizumab + chemotherapy versus chemotherapy and pembrolizumab monotherapy in first line treatment of NSCLC in the US - updated analyses with additional trial follow-up.
J Med Econ
; 24(1): 792-805, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34098842
20.
Pharmacologic Interventions for Breathlessness in Patients With Advanced Cancer: A Systematic Review and Meta-analysis.
JAMA Netw Open
; 4(2): e2037632, 2021 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33630086